Penicilliosis: An AIDS-defining disease in Asia

Hong Kong Medical Journal

Volumn 14, Issue 2, 2008, Pages 88-89

  Lee, Nelson ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ECHINOCANDIN; GALACTOMANNAN; ITRACONAZOLE; MANNOPROTEIN; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASIA; ASPERGILLOSIS; BLOOD CULTURE; EDITORIAL; FUNGUS CULTURE; FUNGUS TRANSMISSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HONG KONG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MORTALITY; MYCOSIS; OCCUPATIONAL DISEASE; OPPORTUNISTIC INFECTION; PENICILLIOSIS; PENICILLIUM MARNEFFEI; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; THAILAND; TREATMENT RESPONSE; TUBERCULOSIS; AIDS RELATED COMPLEX; CROSS-SECTIONAL STUDY; DERMATOMYCOSIS; DIFFERENTIAL DIAGNOSIS; ENDEMIC DISEASE; LUNG MYCOSIS; NOTE; PENICILLIUM; PROGNOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CROSS-SECTIONAL STUDIES; DERMATOMYCOSES; DIAGNOSIS, DIFFERENTIAL; ENDEMIC DISEASES; HONG KONG; HUMANS; LUNG DISEASES, FUNGAL; PENICILLIUM; PROGNOSIS;

EID: 47249091345     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. HIV/AIDS Facts and figures. World Health Organization (WHO) website: http://www.who.int/hiv/facts/en/index.html. Accessed 18 Feb 2008.
2. Ruxrungtham K, Brown T, Phanuphak P. HIV/AIDS in Asia. Lancet 2004;364:69-82.
3. HIV / AIDS Surveillance Office. Hong Kong Department of Health website: http://www.info.gov.hk/aids/english/surveillance/aidssurveil.htm. Accessed 18 Feb 2008.
4. Wong KH, Lee SS, Chan KC. Twenty years of clinical human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) in Hong Kong. Hong Kong Med J 2006;12:133-40.
5. Vanittanakom N, Cooper CR Jr, Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev 2006;19:95-110.
6. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 1994;344:110-3.
7. Li PC, Tsui MC, Ma KF. Penicillium marneffei: indicator disease for AIDS in South East Asia. AIDS 1992;6:240-1.
8. Wu TC, Chan JW, Ng CK, Tsang DN, Lee MP, Li PC. Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004. Hong Kong Med J 2008;14:103-9.
9. Huang YT, Hung CC, Liao CH, Sun HY, Chang SC, Chen YC. Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus. J Clin Microbiol 2007;45:2858-62.
10. Huang YT, Hung CC, Hsueh PR. Aspergillus galactomannan antigenemia in penicilliosis marneffei. AIDS 2007;21:1990-1.
11. Wong SS, Wong KH, Hui WT, et al. Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol 2001;39:4535-40.
12. Cao L, Chan KM, Chen D, et al. Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients. J Clin Microbiol 1999;37:981-6.
13. Sirisanthana T, Supparatpinyo K, Perriens J, Nelson KE. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. Clin Infect Dis 1998;26:1107-10.
14. Supparatpinyo K, Perriens J, Nelson KE, Sirisanthana T. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. N Engl J Med 1998;339:1739-43.
15. Supparatpinyo K, Schlamm HT. Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients. Am J Trop Med Hyg 2007;77:350-3.
16. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006;50:917-21.
17. Chaiwarith R, Charoenyos N, Sirisanthana T, Supparatpinyo K. Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART. AIDS 2007;21:365-7.